Clinical Trial to Evaluate the Safety and Efficacy of Scalp Med in Treatment of Patients with Androgenetic Alopecia
January 2008
in “
Journal of Clinical Dermatology
”
Studysummary This study found that a new topical agent, Scalp medⓇ, significantly improved hair count and thickness in men with androgenetic alopecia after 24 weeks of treatment.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on kci.go.kr →